Form 4: Red Violet CFO Sells 10,000 Shares, Retains Significant Holdings

Sentiment:

SEC Form 4 Filing 25 November 2024 6:10 PM

Red Violet's Chief Financial Officer, Daniel MacLachlan, sold 10,000 shares of common stock at $37.25 per share, while still holding a substantial amount of shares and restricted stock units.

Summary

Daniel MacLachlan, the Chief Financial Officer of Red Violet, Inc., sold 10,000 shares of common stock on November 25, 2024, at a price of $37.25 per share.
Following the transaction, Mr. MacLachlan directly owns 399,584 shares of Red Violet common stock.
He also indirectly owns 466 shares held through an IRA.
Mr. MacLachlan holds a significant number of Restricted Stock Units (RSUs) that are convertible into common stock, with various vesting schedules.
These RSUs include 13,333 granted on October 12, 2022, vesting on November 1, 2025, 40,000 granted on November 30, 2023, vesting in three equal installments starting December 1, 2024, and 31,500 granted on November 4, 2024, vesting in three equal installments starting November 1, 2025.

Sentiment

Score: 6

Explanation: The document is neutral, detailing a routine insider transaction. There are no significant positive or negative implications.

Positives

The CFO still retains a significant amount of shares and RSUs, indicating continued alignment with the company's success.
The sale represents a small portion of his overall holdings.

Negatives

The sale of 10,000 shares could be interpreted as a slight decrease in confidence by the CFO, although it is a small portion of his holdings.

Risks

While the sale is not substantial, further sales by insiders could negatively impact investor sentiment.
The vesting of a large number of RSUs in the future could potentially increase the number of shares available in the market.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders buy or sell shares. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

Form 4 filings are a standard practice for all publicly traded companies in the US, ensuring transparency of insider trading.
The sale of 10,000 shares by the CFO is not unusual and is within the normal range of insider transactions.
The vesting schedules of the RSUs are also typical for executive compensation packages.

Stakeholder Impact

The sale of shares by the CFO may have a minor impact on shareholder sentiment, but it is not expected to be significant given the small portion of his holdings sold.

Key Dates

Date	Description
10/12/2022	Date of original grant of 13,333 Restricted Stock Units (RSUs).
11/30/2023	Date of original grant of 40,000 Restricted Stock Units (RSUs).
11/04/2024	Date of original grant of 31,500 Restricted Stock Units (RSUs).
11/25/2024	Date of the reported sale of 10,000 shares of common stock by the CFO.
12/01/2024	First vesting date for 1/3 of the 40,000 RSUs granted on November 30, 2023.
11/01/2025	Vesting date for the 13,333 RSUs granted on October 12, 2022 and first vesting date for 1/3 of the 31,500 RSUs granted on November 4, 2024.
12/01/2025	Second vesting date for 1/3 of the 40,000 RSUs granted on November 30, 2023.
11/01/2026	Second vesting date for 1/3 of the 31,500 RSUs granted on November 4, 2024.
12/01/2026	Final vesting date for 1/3 of the 40,000 RSUs granted on November 30, 2023.
11/01/2027	Final vesting date for 1/3 of the 31,500 RSUs granted on November 4, 2024.

Keywords

Red Violet, RDVT, insider trading, Form 4, Daniel MacLachlan, CFO, stock sale, restricted stock units, RSU, share ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.